New FDA Enforcement Memo Clears Way For Hemp CBD Product Coverage Under New Medicare Plan
The Food and Drug Administration (FDA) has issued guidance making clear that it does not intend to interfere with implementation of a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. FDA Commissioner Marty Makary wrote in a two-page memo on Wednesday that the agency […]
White House Schedules More Meetings On Cannabis Product Enforcement Policy From FDA For This Week
The White House now scheduled a total of four meetings with cannabis industry and research stakeholders this week to discuss a proposed enforcement policy for CBD products. The Office of Information and Regulatory Affairs (OIRA) under the White House Office of Management and Budget (OMB) announced earlier this month that it plans to review yet-unpublished guidance […]
The FDA Is Done Ignoring CBD. Its Free Ride May Be Over
The agency has quietly sent a CBD compliance and enforcement policy to the White House for review, a move that could bring long-overdue standards to a chaotic market while opening the door to a new layer of federal control. The FDA has finally made a real move on CBD. On March 13, 2026, the agency […]
FDA Submits New Cannabis Products Enforcement Policy For White House Review
The Food and Drug Administration (FDA) has submitted a proposed cannabis products enforcement policy to the White House for review that concerns regulatory issues specifically related to CBD. The White House Office of Management and Budget’s (OMB) Office of Information and Regulatory Affairs (OIRA) posted a notice that it received the submission from FDA, which […]